Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05473663 · ClinicalTrials.gov registry record · NA

Radiofrequency Ablation After Total Knee Arthroplasty

A NA study of Chronic Knee Pain, sponsored by University of Massachusetts, Worcester.

Active
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT05473663: Active NA study of Chronic Knee Pain, sponsored by University of Massachusetts, Worcester.

NCT05473663 is a NA study of Chronic Knee Pain that is active but no longer recruiting, run by University of Massachusetts, Worcester. The registered enrollment target is 14 participants, below the 231-participant average among 5 other Chronic Knee Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05473663, a NA study of Chronic Knee Pain, is active but no longer recruiting, sponsored by University of Massachusetts, Worcester.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess how clinically useful and safe genicular nerve radiofrequency ablation is in people with chronic pain after total knee arthroplasty performed for osteoarthritis.

Primary Outcome

Our a priori decision rule for acceptability of RFA will be that 50% of the actively treated participants respond affirmatively at the 3-month visit: "Would you recommend the treatment used in this study to someone in a similar situation with knee pain after a knee replacement?"

Conditions Studied

Interventions

  • DEVICE Radiofrequency Ablation
  • DEVICE Sham

Study Locations (1)

Massachusetts

  • University of Massachusetts Chan Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2022-09-01
Est. Completion 2026-09-30
Phase NA

What the registry record for NCT05473663 still lists

NCT05473663 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 231-participant average among 5 other Chronic Knee Pain trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Chronic Knee Pain appearing as the primary indexed condition, and to 2 interventions - of which Radiofrequency Ablation is the first listed.

NCT05473663 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05473663 about?

NCT05473663 is a clinical study titled "Radiofrequency Ablation After Total Knee Arthroplasty". The purpose of this study is to assess how clinically useful and safe genicular nerve radiofrequency ablation is in people with chronic pain after total knee arthroplasty performed for osteoarthritis.

What is the current status of trial NCT05473663?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2022-09-01. Estimated completion is 2026-09-30.

What conditions does trial NCT05473663 study?

This clinical trial studies the following conditions: Chronic Knee Pain.

What interventions are being tested in trial NCT05473663?

The interventions under investigation include: Radiofrequency Ablation (DEVICE), Sham (DEVICE).

Who is sponsoring clinical trial NCT05473663?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05473663 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Knee Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05473663, the US trial registry maintained by the National Library of Medicine. NCT05473663 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.